Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency

Intern Med. 2010;49(3):243-7. doi: 10.2169/internalmedicine.49.2712. Epub 2010 Feb 1.

Abstract

Citrin deficiency caused by SLC25A13 gene mutations develops into adult-onset type II citrullinemia (CTLN2) presenting with hepatic encephalopathy. Recent studies have suggested that excessive loading of carbohydrates is harmful in citrin-deficient individuals. Here we report a CTLN2 patient who showed further deterioration of encephalopathy after the employment of conventional low-protein diet therapy for chronic liver failure. Owing to the high carbohydrate content, the conventional low-protein diet therapy should be avoided in patients with hepatic encephalopathy associated with citrin deficiency. In addition, our observation may suggest that carbohydrate-restricted diet in which the content of carbohydrate is below 50% of daily energy intake can have therapeutic efficacy in CTLN2 patients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arginine / therapeutic use*
  • Citrullinemia / chemically induced
  • Citrullinemia / complications*
  • Diet, Protein-Restricted / adverse effects*
  • Dietary Supplements*
  • Gene Deletion
  • Hepatic Encephalopathy / complications
  • Hepatic Encephalopathy / diet therapy*
  • Hepatic Encephalopathy / etiology
  • Humans
  • Hyperammonemia / diet therapy*
  • Male
  • Middle Aged
  • Mitochondrial Membrane Transport Proteins / genetics

Substances

  • Mitochondrial Membrane Transport Proteins
  • SLC25A13 protein, human
  • Arginine